New FDA-approved drug for vision loss now available at Retina Health Center

2016-11-08T15:00:46-05:00August 14th, 2012|Categories: News|Tags: , , , , , |

Following a three-year year clinical study at Retina Health Center and other participating eye centers around the country, the FDA has approved the use of the injectable drug Lucentis for the treatment of diabetic macular edema. Diabetic macular edema occurs when fluid accumulates on or under the macular (the center of the retina) and causes [...]